Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Meningioma canino: Relato de caso

2018; Editora MV Valero; Volume: 12; Issue: 02 Linguagem: Inglês

10.22256/pubvet.v12n2a26.1-4

1982-1263

Lourival De sousa brito pereira, Homero Firmo Pessoa, Gabriela de Paiva Sousa, Lucilo Bioni da Fonsêca Filho, Ana Luisa Guimarães Bessa, Priscilla Virgínio de Albuquerque, Silvia Fernanda de Alcântara, JúlioCézar dos Santos Nascimento, Marleyne José Afonso Accioly Lins Amorim,

Meningioma and schwannoma management

Meningioma is the most common intracranial neoplasia in dogs in the veterinary clinic, in most cases it has a benign nature, and may arise in any of the three meninges that cover and protect the central nervous system. The main clinical sign of meningioma is seizure, but behavioral alterations have been reported frequently in the literature. Lomustine, because it is highly soluble in lipids, reaches high concentrations in the brain-spinal fluid allowing it to be used as a chemotherapeutic protocol for patients with meningioma. The objective of this work was to report a case of intracranial meningioma in a poodle dog at the age of ten, highlighting its clinical evolution, presumptive diagnosis and therapeutic behavior.